In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients

The potent anti-tumour activities of γδ T cells have prompted the development of protocols in which γδ-agonists are administered to cancer patients. Encouraging results from small Phase I trials have fuelled efforts to characterize more clearly the application of this approach to unmet clinical need...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Meraviglia, S, Eberl, M, Vermijlen, D, Todaro, M, Buccheri, S, Cicero, G, La Mendola, C, Guggino, G, D'Asaro, M, Orlando, V, Scarpa, F, Roberts, A, Caccamo, N, Stassi, G, Dieli, F, Hayday, A C
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Inc 2010
Assuntos:
Translational Studies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2909411/
https://ncbi.nlm.nih.gov/pubmed/20491785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2010.04167.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados